Use of Inhibitors of Scinderin and/or Ephrin-A1 for Treating Tumors
    2.
    发明申请
    Use of Inhibitors of Scinderin and/or Ephrin-A1 for Treating Tumors 失效
    使用Scinderin和/或Ephrin-A1抑制剂治疗肿瘤

    公开(公告)号:US20090156531A1

    公开(公告)日:2009-06-18

    申请号:US12159460

    申请日:2006-12-28

    申请人: Salem Chouaib

    发明人: Salem Chouaib

    摘要: The invention relates to the use of inhibitors of the expression or the activity of scinderin and/or of ephrin-A1 inhibitors for increasing the susceptibility of tumor cells to CTL killing. Such inhibitors may be for instance interfering RNAs targeting the scinderin gene and/or interfering RNAs targeting the ephrin-A1 gene.

    摘要翻译: 本发明涉及使用scinderin和/或ephrin-A1抑制剂的表达或活性的抑制剂来增加肿瘤细胞对CTL杀伤的敏感性。 这样的抑制剂可以是例如靶向靶向ephrin-A1基因的scinderin基因和/或干扰RNA的干扰RNA。